Australia Seeks to Authorize New Source of 2'-Fucosyllactose as a Nutrient in Infant Formula
On September 23, 2025, Food Standards Australia New Zealand (FSANZ) published application A1340, proposing to approve the use of 2'-Fucosyllactose (2'-FL) produced using a genetically modified E. coli BL21 (DE3) strain as a nutritional ingredient in infant formula products. The proprietary production technology is exclusively held by Yixi Biotechnology Co., Ltd. from Jiangsu, China.
Sep 24, 2025